As of 3:50pm ET
| -0.05 / -2.12%|
The 1 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +29.87% increase from the last price of 2.31.
The current consensus among 1 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.